AstraZeneca Imfinzi combination fails advanced lung cancer study - Reuters
AstraZeneca Imfinzi combination fails advanced lung cancer study Reuters
(Reuters) - A combination of AstraZeneca's lung cancer drug Imfinzi and an experimental treatment failed to extend the lives of patients with advanced non-small ...
Comments
Post a Comment